RedHill initiates enforcement of $10.9 million judgment in Korea Jun 8, 2026 07:01AM
Cumberland reports positive cancer trial results for ifetroban drug Jun 2, 2026 09:06AM
RedHill explores opaganib for ebola outbreak response Jun 2, 2026 08:00AM
Cumberland Pharmaceuticals (CPIX) Reports Q1 Loss of $0.13 May 5, 2026 05:29PM
RedHill's RHB-204 shows comparable efficacy to RHB-104 in lab tests Apr 30, 2026 07:03AM


Apr 23, 2026 09:02AM Cumberland Pharmaceuticals to sell commercial unit to Apotex for $100 million
Apr 16, 2026 09:06AM Cumberland Pharmaceuticals gets FDA approval for expanded Caldolor indication
Nov 4, 2025 05:23PM Cumberland Pharmaceuticals (CPIX) Reports Q3 Loss of $0.06
Oct 20, 2025 09:05AM Cumberland Pharmaceuticals partners with RedHill for Talicia commercialization
Oct 1, 2025 09:06AM Cumberland Pharmaceuticals gets Mexico approval for injectable ibuprofen
Aug 5, 2025 04:39PM Cumberland Pharmaceuticals (CPIX) Reports Q2 Loss of $0.02
Aug 4, 2025 09:05AM Cumberland Pharmaceuticals secures Vizient contract for Vibativ antibiotic
Jun 23, 2025 09:06AM Cumberland Pharmaceuticals (CPIX) Shares Phase 2 FIGHT DMD Trial Results
May 27, 2025 04:09PM Cumberland Pharmaceuticals (CPIX) announces results from study on Caldolor
May 6, 2025 04:23PM Cumberland Pharmaceuticals (CPIX) Reports Q1 EPS of $0.16
Mar 4, 2025 04:06PM Cumberland Pharmaceuticals (CPIX) Reports Q4 Loss of $0.14
Feb 4, 2025 07:30AM Cumberland Pharmaceuticals (CPIX) Announces Results from the Phase 2 FIGHT DMD Trial
Dec 10, 2024 08:24AM Cumberland Pharmaceuticals (CPIX): FDA Approves Acetadote SNDA
Nov 7, 2024 04:38PM Cumberland Pharmaceuticals (CPIX) Reports Q3 Loss of $0.11
Nov 6, 2024 05:22PM Cumberland Pharmaceuticals (CPIX) Receives FDA Orphan Drug Designation and Rare Pediatric Disease Designation for Ifetroban
Aug 6, 2024 04:51PM Cumberland Pharmaceuticals (CPIX) Reports Q2 EPS of $0.01